It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Primary ciliary dyskinesia (PCD) is a rare autosomal recessive condition often presenting with chronic respiratory infections in early life. Transmission electron microscopy (TEM) is used to detect ciliary ultrastructural defects. In this study, we aimed to assess ciliary ultrastructural defects using quantitative methods on TEM to identify its diagnostic role in confirming PCD. Nasal samples of 67 patients, including 37 females and 30 males (20.3 ± 10.7 years old), with suspected PCD symptoms were examined by TEM. The most common presentations were bronchiectasis: 26 (38.8%), chronic sinusitis: 23 (34.3%), and recurrent lower respiratory infections: 21 (31.3%). Secondary ciliary dyskinesia, including compound cilia (41.4%) and extra-tubules (44.3%), were the most prevalent TEM finding. Twelve patients (17.9%) had hallmark diagnostic criteria for PCD (class 1) consisting of 11 (16.4%) outer and inner dynein arm (ODA and IDA) defects and only one concurrent IDA defect and microtubular disorganization. Also, 11 patients (16.4%) had probable criteria for PCD (class 2), 26 (38.8%) had other defects, and 18 (26.9%) had normal ciliary ultrastructure. Among our suspected PCD patients, the most common ultrastructural ciliary defects were extra-tubules and compound cilia. However, the most prevalent hallmark diagnostic defect confirming PCD was simultaneous defects of IDA and ODA.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Shahid Beheshti University of Medical Sciences, Department of Pathology, School of Medicine, Tehran, Iran (GRID:grid.411600.2); Shahid Beheshti University of Medical Sciences, Clinical Tuberculosis and Epidemiology Research Centre, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran (GRID:grid.411600.2)
2 Shahid Beheshti University of Medical Sciences, Medical Student Research Committee, School of Medicine, Tehran, Iran (GRID:grid.411600.2)
3 Shahid Beheshti University of Medical Sciences, Department of Pharmacology, School of Medicine, Tehran, Iran (GRID:grid.411600.2)
4 Shahid Beheshti University of Medical Sciences, Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran (GRID:grid.411600.2)
5 Shahid Beheshti University of Medical Sciences, Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Tehran, Iran (GRID:grid.411600.2)
6 Shahid Beheshti University of Medical Sciences, Pediatric Respiratory Disease Research Centre, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran (GRID:grid.411600.2)
7 Shahid Beheshti University of Medical Sciences, Central Lab, School of Medicine, Tehran, Iran (GRID:grid.411600.2)
8 Shahid Beheshti University of Medical Sciences, Clinical Tuberculosis and Epidemiology Research Centre, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran (GRID:grid.411600.2)